keyword
https://read.qxmd.com/read/38599763/living-donor-lung-transplantation-after-hematopoietic-stem-cell-transplantation-from-the-same-donor-a-risk-worth-taking
#21
Stefania Camagni, Lorenzo D'Antiga, Fabiano Di Marco, Lorenzo Grazioli, Ezio Bonanomi, Domenico Pinelli, Marta Beretta, Veronica Tintori, Alessandro Lucianetti, Michele Colledan
Living donor (LD) lung transplantation (LT) represents an exceptional procedure in Western countries. However, in selected situations, it could be a source of unique advantages, besides addressing organ shortage. We report a successful case of father-to-child single-lobe LT, because of the complications of hematopoietic stem cell transplantation from the same donor, with initial low-dose immunosuppressive therapy and subsequent early discontinuation. Full donor chimerism was hypothesized to be a mechanism of transplant tolerance, and this postulated immunological benefit was deemed to outweigh the risks of living donation and the possible drawbacks of single compared with bilateral LT...
April 2024: Chest
https://read.qxmd.com/read/38598345/pharmacological-expansion-of-type-2-alveolar-epithelial-cells-promotes-regenerative-lower-airway-repair
#22
JOURNAL ARTICLE
Sida Shao, Nan Zhang, Gregory P Specht, Shaochen You, Lirui Song, Qiangwei Fu, David Huang, Hengyao You, Jian Shu, Alain Domissy, Shuangwei Li, Van Nguyen-Tran, Sean B Joseph, Arnab K Chatterjee, Jeffrey Jian Chen, Peter G Schultz, Michael J Bollong
Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to lower airway repair. Agents that promote the selective expansion of these cells might stimulate regeneration of the compromised alveolar epithelium, an etiology-defining event in several pulmonary diseases. From a high-content imaging screen of the drug repurposing library ReFRAME, we identified that dipeptidyl peptidase 4 (DPP4) inhibitors, widely used type 2 diabetes medications, selectively expand AEC2s and are broadly efficacious in several mouse models of lung damage...
April 16, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38598059/unlocking-the-potential-of-extracellular-vesicles-as-the-next-generation-therapy-challenges-and-opportunities
#23
REVIEW
Syahidatulamali Che Shaffi, Omar Nafiis Hairuddin, Siti Farizan Mansor, Tengku Muhamad Faris Syafiq, Badrul Hisham Yahaya
BACKGROUND: Mesenchymal stem cells (MSCs) have undergone extensive investigation for their potential therapeutic applications, primarily attributed to their paracrine activity. Recently, researchers have been exploring the therapeutic potential of extracellular vesicles (EVs) released by MSCs. METHODS: MEDLINE/PubMed and Google scholar databases were used for the selection of literature. The keywords used were mesenchymal stem cells, extracellular vesicles, clinical application of EVs and challenges EVs production...
April 10, 2024: Tissue Engineering and Regenerative Medicine
https://read.qxmd.com/read/38593797/patient-derived-tumor-like-cell-clusters-for-personalized-chemo-and-immunotherapies-in-non-small-cell-lung-cancer
#24
JOURNAL ARTICLE
Shenyi Yin, Ying Yu, Nan Wu, Minglei Zhuo, Yanmin Wang, Yanjie Niu, Yiqian Ni, Fang Hu, Cuiming Ding, Hongsheng Liu, Xinghua Cheng, Jin Peng, Juan Li, Yang He, Jiaxin Li, Junyi Wang, Hanshuo Zhang, Xiaoyu Zhai, Bing Liu, Yaqi Wang, Shi Yan, Mailin Chen, Wenqing Li, Jincui Peng, Fei Peng, Ruibin Xi, Buqing Ye, Liyan Jiang, Jianzhong Jeff Xi
Many patient-derived tumor models have emerged recently. However, their potential to guide personalized drug selection remains unclear. Here, we report patient-derived tumor-like cell clusters (PTCs) for non-small cell lung cancer (NSCLC), capable of conducting 100-5,000 drug tests within 10 days. We have established 283 PTC models with an 81% success rate. PTCs contain primary tumor epithelium self-assembled with endogenous stromal and immune cells and show a high degree of similarity to the original tumors in phenotypic and genotypic features...
April 2, 2024: Cell Stem Cell
https://read.qxmd.com/read/38592804/cytotoxicity-and-multi-enzyme-inhibition-of-nepenthes-miranda-stem-extract-on-h838-human-non-small-cell-lung-cancer-cells-and-rpa32-elastase-tyrosinase-and-hyaluronidase-proteins
#25
JOURNAL ARTICLE
Ching-Yi Lee, Yu-Cheng Chen, Yen-Hua Huang, Yi Lien, Cheng-Yang Huang
The carnivorous pitcher plants of the genus Nepenthes have long been known for their ethnobotanical applications. In this study, we prepared various extracts from the pitcher, stem, and leaf of Nepenthes miranda using 100% ethanol and assessed their inhibitory effects on key enzymes related to skin aging, including elastase, tyrosinase, and hyaluronidase. The cytotoxicity of the stem extract of N. miranda on H838 human lung carcinoma cells were also characterized by effects on cell survival, migration, proliferation, apoptosis induction, and DNA damage...
March 11, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38590234/prognostic-effect-of-tcf1-cd8-t-cell-and-tox-cd8-t-cell-infiltration-in-lung-adenocarcinoma
#26
JOURNAL ARTICLE
Yao Wang, Lin Ma, Yu Chen, Wenhua Yun, Jinming Yu, Xiangjiao Meng
Recent studies have highlighted the pivotal roles of T cell transcription factors TCF-1 and TOX in modulating the immune response in cancer, with TCF-1 maintaining CD8+ T cell stemness and TOX promoting T cell exhaustion. The prognostic significance of these factors in lung adenocarcinoma (LUAD) remains a critical area of investigation. The retrospective study included 191 patients with LUAD who underwent surgery, of whom 83% were in stages II and III. These patients were divided into exploratory (n = 135) and validation (n = 56) groups based on the time of diagnosis...
April 9, 2024: Cancer Science
https://read.qxmd.com/read/38589907/cdc45-promotes-the-stemness-and-metastasis-in-lung-adenocarcinoma-by-affecting-the-cell-cycle
#27
JOURNAL ARTICLE
Yafeng Liu, Tao Han, Zhi Xu, Jing Wu, Jiawei Zhou, Jianqiang Guo, Rui Miao, Yingru Xing, Deyong Ge, Ying Bai, Dong Hu
OBJECTIVE: This study aimed to assess the functions of cell division cycle protein 45 (CDC45) in Non-small cell lung cancer (NSCLC) cancer and its effects on stemness and metastasis. METHODS: Firstly, differentially expressed genes related to lung cancer metastasis and stemness were screened by differential analysis and lasso regression. Then, in vitro, experiments such as colony formation assay, scratch assay, and transwell assay were conducted to evaluate the impact of CDC45 knockdown on the proliferation and migration abilities of lung cancer cells...
April 8, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38589357/p53-promotes-revival-stem-cells-in-the-regenerating-intestine-after-severe-radiation-injury
#28
JOURNAL ARTICLE
Clara Morral, Arshad Ayyaz, Hsuan-Cheng Kuo, Mardi Fink, Ioannis I Verginadis, Andrea R Daniel, Danielle N Burner, Lucy M Driver, Sloane Satow, Stephanie Hasapis, Reem Ghinnagow, Lixia Luo, Yan Ma, Laura D Attardi, Constantinos Koumenis, Andy J Minn, Jeffrey L Wrana, Chang-Lung Lee, David G Kirsch
Ionizing radiation induces cell death in the gastrointestinal (GI) epithelium by activating p53. However, p53 also prevents animal lethality caused by radiation-induced acute GI syndrome. Through single-cell RNA-sequencing of the irradiated mouse small intestine, we find that p53 target genes are specifically enriched in regenerating epithelial cells that undergo fetal-like reversion, including revival stem cells (revSCs) that promote animal survival after severe damage of the GI tract. Accordingly, in mice with p53 deleted specifically in the GI epithelium, ionizing radiation fails to induce fetal-like revSCs...
April 8, 2024: Nature Communications
https://read.qxmd.com/read/38588407/integrin-%C3%AE-v%C3%AE-3-upregulation-in-response-to-nutrient-stress-promotes-lung-cancer-cell-metabolic-plasticity
#29
JOURNAL ARTICLE
Arin Nam, Shashi Jain, Chengsheng Wu, Alejandro Campos, Ryan M Shepard, Ziqi Yu, Joshua P Reddy, Tami Von Schalscha, Sara M Weis, Mark Onaitis, Hiromi I Wettersten, David A Cheresh
UNLABELLED: Cancer stem/tumor-initiating cells display stress tolerance and metabolic flexibility to survive in a harsh environment with limited nutrient and oxygen availability. The molecular mechanisms underlying this phenomenon could provide targets to prevent metabolic adaptation and halt cancer progression. Here, we showed in cultured cells and live human surgical biopsies of non-small cell lung cancer that nutrient stress drives the expression of the epithelial cancer stem cell marker integrin αvβ3 via upregulation of the β3 subunit, resulting in a metabolic reprogramming cascade that allows tumor cells to thrive despite a nutrient-limiting environment...
April 8, 2024: Cancer Research
https://read.qxmd.com/read/38585863/impaired-ampk-control-of-alveolar-epithelial-cell-metabolism-promotes-pulmonary-fibrosis
#30
Luis R Rodriguez, Konstantinos-Dionysios Alysandratos, Jeremy Katzen, Aditi Murthy, Willy Roque Barboza, Yaniv Tomer, Rebeca Acin-Perez, Anton Petcherski, Kasey Minakin, Paige Carson, Swati Iyer, Katrina Chavez, Charlotte H Cooper, Apoorva Babu, Aaron I Weiner, Andrew E Vaughan, Zoltan Arany, Orian S Shirihai, Darrell N Kotton, Michael F Beers
Alveolar epithelial type II (AT2) cell dysfunction is implicated in the pathogenesis of familial and sporadic idiopathic pulmonary fibrosis (IPF). We previously described that expression of an AT2 cell exclusive disease-associated protein isoform (SP-CI73T) in murine and patient-specific induced pluripotent stem cell (iPSC)-derived AT2 cells leads to a block in late macroautophagy and promotes time-dependent mitochondrial impairments; however, how a metabolically dysfunctional AT2 cell results in fibrosis remains elusive...
March 28, 2024: bioRxiv
https://read.qxmd.com/read/38583771/genome-wide-analysis-identifies-nuclear-factor-1c-as-a-novel-transcription-factor-and-potential-therapeutic-target-in-small-cell-lung-cancer
#31
JOURNAL ARTICLE
Vivek Shukla, Haitao Wang, Lyuba Varticovski, Songjoon Baek, Ruihong Wang, Xinwei Wu, Frank Echtenkamp, Frank Villa Hernandez, Katherine P Prothro, Sudheer K Gara, Mary R Zhang, Stephanie Shiffka, Razi Raziuddin, Leonard M Neckers, W Marston Linehan, Haobin Chen, Gordon L Hager, David S Schrump
BACKGROUND: Recent insights regarding mechanisms mediating stemness, heterogeneity, and metastatic potential of lung cancers have yet to be fully translated to effective regimens for the treatment of these malignancies. This study sought to identify novel targets for lung cancer therapy. METHODS: Transcriptomes and DNA methylomes of 14 SCLC and 10 NSCLC lines were compared to normal human small airway epithelial cells (SAEC) and induced pluripotent stem cell (iPSC) clones derived from SAEC...
April 5, 2024: Journal of Thoracic Oncology
https://read.qxmd.com/read/38582877/a-placebo-controlled-crossover-trial-to-investigate-the-efficacy-of-tiotropium-bromide-or-placebo-added-to-usual-care-in-stable-symptomatic-post-hematopoietic-stem-cell-transplantation-hsct-bronchiolitis-obliterans-syndrome-bos
#32
JOURNAL ARTICLE
Naeemeh Dini, Amin Pastaki Khoshbin, Rasoul Aliannejad, Hooman Bakhshandeh, Katayoun Najafizadeh, Mahshid Mehdizadeh, Shahideh Amini
BACKGROUND: Despite the fundamental progress in hematopoietic stem cell transplant, this treatment is also associated with complications. Graft-versus-host disease is a possible complication of HSCT. Bronchiolitis obliterans syndrome (BOS) is the pulmonary form of this syndrome. Due to the high morbidity and mortality rate of BOS, various studies have been conducted in the field of drug therapy for this syndrome, although no standard treatment has yet been proposed. According to the hypotheses about the similarities between BOS and chronic obstructive pulmonary disease, the idea of using tiotropium bromide as a bronchodilator has been proposed...
April 6, 2024: Trials
https://read.qxmd.com/read/38581619/lung-derived-soluble-factors-support-stemness-plasticity-and-metastatic-behaviour-of-breast-cancer-cells-via-the-fgf2-dach1-axis
#33
JOURNAL ARTICLE
Vasudeva Bhat, Matthew Piaseczny, David Goodale, Urvi Patel, Ashkan Sadri, Alison L Allan
Patients with triple-negative breast cancer (TNBC) have an increased propensity to develop lung metastasis. Our previous studies demonstrated that stem-like ALDHhi CD44+ breast cancer cells interact with lung-derived soluble factors, resulting in enhanced migration and lung metastasis particularly in TNBC models. We have also observed that the presence of a primary TNBC tumor can 'prime' the lung microenvironment in preparation for metastasis. In this study, we hypothesized that soluble lung-derived factors secreted in the presence of a primary TNBC tumor can influence stemness/plasticity of breast cancer cells...
April 6, 2024: Clinical & Experimental Metastasis
https://read.qxmd.com/read/38579712/tracing-the-origin-of-alveolar-stem-cells-in-lung-repair-and-regeneration
#34
JOURNAL ARTICLE
Kuo Liu, Xinfeng Meng, Zixin Liu, Muxue Tang, Zan Lv, Xiuzhen Huang, Hengwei Jin, Ximeng Han, Xiuxiu Liu, Wenjuan Pu, Huan Zhu, Bin Zhou
Alveolar type 2 (AT2) cells are stem cells of the alveolar epithelia. Previous genetic lineage tracing studies reported multiple cellular origins for AT2 cells after injury. However, conventional lineage tracing based on Cre-loxP has the limitation of non-specific labeling. Here, we introduced a dual recombinase-mediated intersectional genetic lineage tracing approach, enabling precise investigation of AT2 cellular origins during lung homeostasis, injury, and repair. We found AT1 cells, being terminally differentiated, did not contribute to AT2 cells after lung injury and repair...
March 27, 2024: Cell
https://read.qxmd.com/read/38579324/therapeutic-management-of-fibrosis-in-systemic-sclerosis-patients-an-analysis-from-the-swiss-eustar-cohort
#35
JOURNAL ARTICLE
Kevin Windirsch, Suzana Jordan, Mike Oliver Becker, Cosimo Bruni, Rucsandra Dobrota, Muriel Elhai, Ion-Alexandru Garaiman, Carmen-Marina Mihai, Michele Iudici, Paul Hasler, Camillo Ribi, Britta Maurer, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Oliver Distler
OBJECTIVES: Systemic sclerosis is a chronic autoimmune connective tissue disease leading to microvascular and fibrotic manifestations in multiple organs. Several treatment options and recommendations from different European countries are available. In this study, for which the ambit is Switzerland specifically, we aim to describe the treatment patterns of systemic sclerosis patients with fibrotic manifestations. METHODS: Systemic sclerosis patients were selected from six Swiss tertiary centres recorded in the multicentre, prospective European Scleroderma Trials and Research (EUSTAR) registry...
February 6, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38578337/letermovir-prophylaxis-for-cytomegalovirus-in-lung-transplant-recipients-a-comprehensive-study-with-literature-review-of-off-label-use-and-real-world-experiences
#36
JOURNAL ARTICLE
Takashi Hirama, Yuki Shundo, Toshikazu Watanabe, Akihiro Ohsumi, Tatsuaki Watanabe, Yoshinori Okada
Letermovir, initially approved for cytomegalovirus (CMV) prophylaxis in hematopoietic stem-cell transplantation, has gained attention for off-label use in lung-transplant (LTx) recipients. Given the high susceptibility of LTx recipients to CMV infection, this study explores the effectiveness and safety of letermovir prophylaxis. A retrospective analysis of using letermovir for LTx recipients at Tohoku University Hospital (January 2000 to November 2023) was conducted. Case summaries from other Japanese transplant centers and a literature review were included...
April 5, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38576851/multipotent-adult-progenitor-cells-prevent-functional-impairment-and-improve-development-in-inflammation-driven-detriment-of-preterm-ovine-lungs
#37
JOURNAL ARTICLE
Sophie M L Neuen, Daan R M G Ophelders, Helene Widowski, Matthias C Hütten, Tim Brokken, Charlotte van Gorp, Peter G J Nikkels, Carmen A H Severens-Rijvers, Mireille M J P E Sthijns, Clemens A van Blitterswijk, Freddy J Troost, Vanessa L S LaPointe, Shahab Jolani, Christof Seiler, J Jane Pillow, Tammo Delhaas, Niki L Reynaert, Tim G A M Wolfs
BACKGROUND: Perinatal inflammation increases the risk for bronchopulmonary dysplasia in preterm neonates, but the underlying pathophysiological mechanisms remain largely unknown. Given their anti-inflammatory and regenerative capacity, multipotent adult progenitor cells (MAPC) are a promising cell-based therapy to prevent and/or treat the negative pulmonary consequences of perinatal inflammation in the preterm neonate. Therefore, the pathophysiology underlying adverse preterm lung outcomes following perinatal inflammation and pulmonary benefits of MAPC treatment at the interface of prenatal inflammatory and postnatal ventilation exposures were elucidated...
December 2024: Regenerative Therapy
https://read.qxmd.com/read/38575614/mitochondrial-dna-as-a-target-for-analyzing-the-biodistribution-of-cell-therapy-products
#38
JOURNAL ARTICLE
Young-Woo Cho, Jaehyeon Yoon, Suk-Gil Song, Young-Woock Noh
Biodistribution tests are crucial for evaluating the safety of cell therapy (CT) products in order to prevent unwanted organ homing of these products in patients. Quantitative polymerase chain reaction (qPCR) using intronic Alu is a popular method for biodistribution testing owing to its ability to detect donor cells without modifying CT products and low detection limit. However, Alu-qPCR may generate inaccurate information owing to background signals caused by the mixing of human genomic DNA with that of experimental animals...
April 4, 2024: Scientific Reports
https://read.qxmd.com/read/38574630/exosome-mir-101-3p-derived-from-bone-marrow-mesenchymal-stem-cells-promotes-radiotherapy-sensitivity-in-non-small-cell-lung-cancer-by-regulating-dna-damage-repair-and-autophagy-levels-through-ezh2
#39
JOURNAL ARTICLE
Hongwen Sun, Runying Zhu, Xijing Guo, Peizhu Zhao, Rui Zhang, Zhongquan Zhao, Hua Zhou
BACKGROUND AND OBJECTIVE: The morbidity rate of non-small cell lung cancer (NSCLC) increases with age, highlighting that NSCLC is a serious threat to human health. The aim of this study was mainly to describe the role of exosomal miR-101-3p derived from bone marrow mesenchymal stem cells (BMSCs) in NSCLC. METHODS: A549 or NCI-H1703 cells (1×105 /mouse) were injected into nude mice to establish an NSCLC animal model. RTqPCR, Western blotting and comet assays were used to assess the changes in gene expression, proteins and DNA damage repair...
April 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38573476/the-main-mechanisms-of-mesenchymal-stem-cell-based-treatments-against-covid-19
#40
REVIEW
Jinling Li, Shipei He, Hang Yang, Lizeai Zhang, Jie Xiao, Chaoyi Liang, Sijia Liu
BACKGROUND: Coronavirus disease 2019 (COVID-19) has a clinical manifestation of hypoxic respiratory failure and acute respiratory distress syndrome. However, COVID-19 still lacks of effective clinical treatments so far. As a promising potential treatment against COVID-19, stem cell therapy raised recently and had attracted much attention. Here we review the mechanisms of mesenchymal stem cell-based treatments against COVID-19, and provide potential cues for the effective control of COVID-19 in the future...
April 4, 2024: Tissue Engineering and Regenerative Medicine
keyword
keyword
88552
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.